The pharmaceutical suppositories market refers to the industry involved in the development, production, and distribution of medications that are formulated as suppositories. Suppositories are solid or semisolid formulations that are inserted into the rectum, vagina, or urethra for local or systemic drug delivery.
Pharmaceutical suppositories offer several advantages, including localized drug delivery to specific anatomical sites, bypassing the gastrointestinal tract, and providing systemic absorption with a reduced risk of degradation by stomach acids or liver metabolism. They are used in various therapeutic areas, including gastrointestinal disorders, pain management, hormonal therapy, and certain infectious diseases. Pharmaceutical Suppositories Market is likely to grow at a rate of 5.9% CAGR by 2027
Pharmaceutical suppositories market By Type:
- Rectal Suppositories
- Vaginal Suppositories
- Urethral Suppositories
Pharmaceutical suppositories market By Base:
- Fatty Bases
- Water Miscible Base
- Emulsifying Bases
Pharmaceutical suppositories market By End User:
- Hospitals & Clinics
- Home Care
- Nursing Home
Pharmaceutical suppositories market By Region:
- North America
- Europe
- Asia Pacific
- Rest of the World
As in the market by type is segregated into rectal suppositories, vaginal suppositories and urethral suppositories. The rectal suppository generated the highest revenue in the Pharmaceutical suppositories market growth. This can be ascribed to the rise in focus on the development of rectal suppository.
On the basis of base, the segmentation is classified as the water-miscible base (soap glycerin suppositories, polyethylene glycol bases, and glycero gelatin base), fatty bases, and emulsifying bases (Massa esterium, witepsol, and massuppol). The emulsifying bases have leaded the base segment with maximum share. Since, emulsifying bases solidify quickly, are nonirritant, and are less liable to get rancid.
On the basis of end-user segment the pharmaceutical suppositories market is segmented into hospitals & clinics, nursing homes, and home care. Where, the hospitals & clinics segment has observed the highest revenue in the market. This is because of the rising inclination of hospitals towards pharmaceutical suppositories to instantly treat pediatric or old patients.
Pharmaceutical suppositories offer several advantages, including localized drug delivery to specific anatomical sites, bypassing the gastrointestinal tract, and providing systemic absorption with a reduced risk of degradation by stomach acids or liver metabolism. They are used in various therapeutic areas, including gastrointestinal disorders, pain management, hormonal therapy, and certain infectious diseases.
Key aspects of the pharmaceutical suppositories market include:
Types of Suppositories:
Rectal Suppositories: These suppositories are inserted into the rectum and are commonly used for local or systemic drug delivery. They can deliver medications for constipation, hemorrhoids, inflammatory bowel disease, and systemic conditions.
Vaginal Suppositories: Vaginal suppositories are inserted into the vagina and are used for local treatment of conditions such as vaginal infections, hormonal therapy, and contraception.
Urethral Suppositories: Urethral suppositories are inserted into the urethra and are primarily used for the treatment of conditions like erectile dysfunction.
The leading players of the market are Bayer Ag, Bliss Gvs Pharma Ltd, Cadila Healthcare Ltd, Church And Dwight Uk Ltd, Cosette Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Novartis International Ag, Pfizer Inc., and Sanofi S.A.
Therapeutic Applications:
Gastrointestinal Disorders: Suppositories are used to deliver medications for conditions like constipation, hemorrhoids, and inflammatory bowel disease, providing local relief or systemic drug absorption.
Pain Management: Suppositories can be formulated with analgesics or anti-inflammatory drugs for localized pain relief, such as rectal suppositories for postoperative pain or vaginal suppositories for menstrual pain.
Hormonal Therapy: Hormones can be delivered through suppositories for hormonal replacement therapy, contraception, or treatment of conditions like menopause or endometriosis.
Infectious Diseases: Suppositories can deliver antimicrobial medications for local treatment of vaginal or rectal infections.
Market Drivers:
Increasing demand for alternative drug delivery systems with improved therapeutic outcomes. Growing prevalence of gastrointestinal disorders and pain-related conditions are propelling the market growth.
Advancements in suppository formulation techniques, including controlled release and enhanced drug bioavailability.
- The report analyzes the geographical highlights in terms of consumption of the product/service within the region also indicates the factors which are affecting the pharmaceutical suppositories market within each region.
- The report comprises of opportunities and challenges faced by the players in the global pharmaceutical suppositories
- The report implies the geographical and segmental analysis which is anticipated to witness the fastest growth.
- Provides competitive outlook which includes the market ranking of the key players, coupled with new product launches, partnerships, business expansions, and acquisition.
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR RECTAL SUPPOSITORIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR VAGINAL SUPPOSITORIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR URETHRAL SUPPOSITORIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR FATTY BASES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR WATER MISCIBLE BASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR EMULSIFYING BASES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR RETAIL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR ONLINE SALES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER CHANNEL, 2021-2027 (USD BILLION)
TABLE 14. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR HOSPITALS & CLINICS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 15. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR HOME CARE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 16. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET VALUE FOR NURSING HOME, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 18. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 19. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 20. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL,2021-2027 (USD BILLION)
TABLE 21. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 22. U.SPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 23. U.SPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 24. U.SPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL,2021-2027 (USD BILLION)
TABLE 25. U.S PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 26. CANADAPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 27. CANADAPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 28. CANADAPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 29. CANADAPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER ,2021-2027 (USD BILLION)
TABLE 30. EUROPEPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 31. EUROPEPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 32. EUROPEPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 33. EUROPEPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, DISTRIBUTION CHANNEL,2021-2027 (USD BILLION)
TABLE 34. EUROPEPHARMACEUTICAL SUPPOSITORIES MARKET VALUE, END USER,2021-2027 (USD BILLION)
TABLE 35. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BYTYPE, 2021-2027 (USD BILLION)
TABLE 36. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET VALUEBY BASE, 2021-2027 (USD BILLION)
TABLE 37. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 38. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 39. U.K PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 40. U.K PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 41. U.K PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 42. U.K PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 43. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 44. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 45. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 46. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 47. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 48. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 49. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 50. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 51. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 52. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 53. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL,2021-2027 (USD BILLION)
TABLE 54. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER,2021-2027 (USD BILLION)
TABLE 55. ROE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE,2021-2027 (USD BILLION)
TABLE 56. ROE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 57. ROE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 58. ROE PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY ENS USER, 2021-2027 (USD BILLION)
TABLE 59. ASIA PACIFC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 60. ASIA PACIFC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 61. ASIA PACIFC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 62. ASIA PACIFC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 63. ASIA PACIFC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 64. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 65. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 66. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 67. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 68. INDIA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 69. INDIA PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 70. INDIA HERPES ZOSTER TREATMETMARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 71. INDIA HERPES ZOSTER TREATMETMARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 72. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE2021-2027 (USD BILLION)
TABLE 73. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 74. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 75. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 76. REST OF APAC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 77. REST OF APAC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 78. REST OF APAC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 79. REST OF APAC PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 80. REST OF WORLD PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 81. REST OF WORLD PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY BASE, 2021-2027 (USD BILLION)
TABLE 82. REST OF WORLD PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 83. REST OF WORLD PHARMACEUTICAL SUPPOSITORIES MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 84. BAYER AG: FINANCIALS
TABLE 85. BAYER AG: PRODUCTS & SERVICES
TABLE 86. BAYER AG: RECENT DEVELOPMENTS
TABLE 87. BLISS GVS PHARMA LTD: FINANCIALS
TABLE 88. BLISS GVS PHARMA LTD: PRODUCTS & SERVICES
TABLE 89. BLISS GVS PHARMA LTD: RECENT DEVELOPMENTS
TABLE 90. CADILA HEALTHCARE LTD: FINANCIALS
TABLE 91. CADILA HEALTHCARE LTD: PRODUCTS & SERVICES
TABLE 92. CADILA HEALTHCARE LTD: RECENT DEVELOPMENTS
TABLE 93. CHURCH AND DWIGHT UK LTD: FINANCIALS
TABLE 94. CHURCH AND DWIGHT UK LTD: PRODUCTS & SERVICES
TABLE 95. CHURCH AND DWIGHT UK LTD: RECENT DEVELOPMENTS
TABLE 96. COSETTE PHARMACEUTICALS, INC: FINANCIALS
TABLE 97. COSETTE PHARMACEUTICALS, INC.: PRODUCTS & SERVICES
TABLE 98. COSETTE PHARMACEUTICALS, INC..: RECENT DEVELOPMENTS
TABLE 99. GLENMARK PHARMACEUTICALS LIMITED: FINANCIALS
TABLE 100. GLENMARK PHARMACEUTICALS LIMITED: PRODUCTS & SERVICES
TABLE 101. GLENMARK PHARMACEUTICALS LIMITED: RECENT DEVELOPMENTS
TABLE 102. NOVARTIS AG: FINANCIALS
TABLE 103. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 104. NOVARTIS AG: RECENT DEVELOPMENTS
TABLE 105. PFIZER INC: FINANCIALS
TABLE 106. PFIZER INC: PRODUCTS & SERVICES
TABLE 107. PFIZER INC: RECENT DEVELOPMENTS
TABLE 108. INTAS PHARMACEUTICALS LTD.: FINANCIALS
TABLE 109. INTAS PHARMACEUTICALS LTD.: PRODUCTS & SERVICES
TABLE 110. INTAS PHARMACEUTICALS LTD.: RECENT DEVELOPMENTS
TABLE 111. SANOFI S.A: FINANCIALS
TABLE 112. SANOFI S.A: PRODUCTS & SERVICES
TABLE 113. SANOFI S.A: RECENT DEVELOPMENTS
